Previous Article | Next Article ![]()
Journal of Virology, December 2002, p. 13123-13124, Vol. 76, No. 24
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.24.13123-13124.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
| LETTER TO THE EDITOR |
First, the rate of phage loss in vitro is many times lower than in natural systems such as in sewage or in vivo. Consequently, the proliferation threshold is expected a priori to be much lower in in vitro experiments such as those of Kasman et al. (1) than in any in vivo system, maybe even too small to measure. Wiggins and Alexander (5) assessed different rates of phage loss, but they were not reported by Kasman et al. If relevant parameter estimates were available, then the proliferation threshold could be predicted using a formula derived from kinetic theory (4). Second, where Kasman et al. use an actual multiplicity of infection of 10, the bacterial infection rate is so high that there are effectively no uninfected cells left for progeny phage to infect: inundation by the initial phage renders any subsequent phage replication or density threshold irrelevant. Kinetic theory predicts that the proliferation threshold is manifested only if the initial phage dose is much smaller than the actual multiplicity of infection of 10 (technically, the phage dose must be less than the "inundation threshold" but more than the "failure threshold" [4]). Third, in natural systems of interest the host cell density typically increases with time. Thus, if the initial cell density is low, it takes a certain time before the proliferation threshold is crossed and thereby made observable. Wiggins and Alexander made this transparent using explicit time series, whereas Kasman et al. took measurements at a fixed time point, which would hinder detection of any time-dependent threshold.
Therefore, that Kasman et al. (1) saw no proliferation threshold probably does not mean that no threshold exists but rather is an expected result of their specific scenario. Kasman et al. mention the profound implications for bacteriophage therapy, but therapeutically what really matters is the possible presence of thresholds in vivo, where phage loss is high. Merril et al. (2) highlighted the importance of the rate of phage loss for the efficacy of bacteriophage therapy in a mouse model, and the kinetic theory (3, 4) clarifies why this makes most in vitro measurements of in vivo processes and outcomes so misleading.
|
|
|---|
|
Robert J. H. Payne* Vincent A. A. Jansen School of Biological Sciences Royal Holloway University of London Egham Surrey TW20 0EX United Kingdom
|
||||||
|
* Phone: 441784-443539 Fax: 441784-434326 E-mail: robert.payne{at}rhul.ac.uk. |
|
|
|---|
Payne and Jansen suggest that our results differ from those of Wiggins and Alexander (4) because phage loss is greater in vivo than in vitro and phage loss was not taken into account. However, only in vitro experiments are reported in reference 4 and our paper (1), both using similar conditions and artificial media. It is also argued that an RT was not detected because the phage dose used was too high. However, all of the definitions of RT are independent of phage dose; therefore, we do not see the rationale for suggesting that an RT would exist for some phage doses and not others. Last, it is suggested that we did not observe an RT because measurements were taken at only one time point. In our experiments, we used a nonreplicating transducing phage; therefore, a time course was not possible. Instead we simulated a time course by mixing a constant dose of phage with separate aliquots of cells, each containing a different cell density which represented a culture at different time points in its growth curve. Moreover, it should be noted that the conclusions of our paper (1) suggest that the model utilized by Payne and Jansen (2, 3) would not be valid over an extended period of time. In particular, by treating the "transmission coefficient" b as a constant, the important role of cell density, which our paper seeks to address, is not taken into account.
We did realize upon receiving this letter and rereading references 2 and 3 that we should have acknowledged Payne and Jansen for suggesting the possibility of using an inundation dose and passive (nonreplicating) phage therapy before us. We very much regret this omission.
|
|
|---|
|
Laura M. Kasman* Caroline Westwater Michael G. Schmidt Joseph Dolan James S. Norris Department of Microbiology and Immunology Medical University of South Carolina Rm. BSB-201 P.O. Box 250504 173 Ashley Ave. Charleston, SC 29403
Alex Kasman
|
||||||
|
* Phone: (843) 792-4362 Fax: (843) 792-2464 E-mail: kasmanl{at}musc.edu. |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»